Mandatory Patient-Focused Listening Sessions with CMS: What Manufacturers Need to Know
The Inflation Reduction Act (IRA) mandates that the Centers for Medicaid & Medicare Services (CMS) negotiate prices for a subset of Part B and Part D drugs, including new mandatory patient-focused listening sessions for each drug selected for price negotiation. Learn more about the patient-focused listening sessions, their potential impact, and how manufacturers can prepare.
Design and Run Drug Development for Real Value for Patients
Create an innovative product that brings medical value for patients. Discover how Alira Health helps biotechs along the journey to reach that goal, structuring the drug development process into a series of clear and reachable value inflection points.
Serving Life Science Clients Globally
Improving the Life of Every Patient
~ Annabel de Maria
Chief Patient Officer
Let us tell you more about how our solutions bridge clinical research with routine medical care to
Gain the Latest Insights with the Alira Health Newsletter
Subscribe to be the first to know the latest news, thought leadership, webinars and events.